• Molecular NameIsoetharine
  • SynonymIsoetarina [INN-Spanish]; Isoetarinum [INN-Latin]; Isoetharine Hcl; Isoetharine mesylate
  • Weight239.315
  • Drugbank_IDDB00221
  • ACS_NO530-08-5
  • Show 2D model
  • LogP (experiment)1.4
  • LogP (predicted, AB/LogP v2.0)0.83
  • pkaN/A
  • LogD (pH=7, predicted)-1.11
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)0.08
  • LogSw (predicted, AB/LogsW2.0)13.78
  • Sw (mg/ml) (predicted, ACD/Labs)4.58
  • No.of HBond Donors4
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds5
  • TPSA72.72
  • StatusFDA approved, US withdrawn
  • AdministrationN/A
  • PharmacologyA selective beta2-adrenergic receptor agonist.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A